Using Clinical Decision Support Tools in IBD: Tricks of the Trade

Program Overview

Through case discussions, learners will gain privileged insights into the treatment strategies of IBD experts, and effective utilization of the Clinical Decision Support Tool (described below) to help stratify patients and provide guidance on optimal treatment selection.

Credit Expired

Target Audience

This activity is designed for gastroenterology and primary care clinicians involved in the care of patients with inflammatory bowel disease (IBD).

Educational Objectives

Upon completion of this activity, participants should be better able to:

Employ predictive decision support tools to guide treatment initiation and timing in patients with inflammatory bowel disease (IBD) according to complication risk and disease severity
Use an individual’s probability of response to treatment to incorporate biologics into therapeutic regimens for IBD
Identify patients with IBD receiving biologic therapy who require more aggressive treatment, such as combination therapy and treat-to-target monitoring

Activity Faculty

Parambir Dulai, MD (Chair)

Assistant Professor
UC San Diego School of Medicine
La Jolla, CA

Niels Vande Casteele, PharmD, PhD

Assistant Professor, Medicine
UC San Diego School of Medicine
La Jolla, CA

Vipul Jairath, MBChB, DPhil, MRCP, FRCPC

Professor, Medicine
Departments of Medicine, Epidemiology and Biostatistics
John and Susan McDonald Endowed Chair, Inflammatory Bowel Disease Clinical Research
Division of Gastroenterology
Western University & London Health Sciences Centre
London, Ontario, Canada

Featured RMEI CE Activities – Earn CE Credit(s)

Using Clinical Decision Support Tools in IBD: Tricks of the Trade

Program Overview

Target Audience

Educational Objectives

Activity Faculty

Parambir Dulai, MD (Chair)

Niels Vande Casteele, PharmD, PhD

Vipul Jairath, MBChB, DPhil, MRCP, FRCPC

Advances in Precision Medicine for Relapsed/Refractory Diffuse Large B-Cell Lymphoma Care: A Care Team Forum®

Refining Management of CMV After Transplant: Exploiting Recent Advances to Alleviate Patient Burden

Overcoming Obstacles to Optimal Multiple Sclerosis (MS) Care in Minority Patient Populations

Subscribe